Lotus Eye Hospital Share Price | Lotus Eye Hospital Stock Screener
LOTUSEYE
Hospitals
Share Price NSE
₹108.30
▼
-1.12 (-1.02%)
Share Price BSE
₹109.20
▼
-1.80 (-1.62%)
As of May 27, 2026, the Lotus Eye Hospital share price (NSE: LOTUSEYE) is ₹108.30 on NSE and ₹109.20 on BSE, down 1.02% from the previous close, with shares trading between ₹107.10 and ₹110.00, and a 52-week range of ₹70.02–₹141.38.
Check LOTUSEYE 52-week performance for the annual price range and momentum.
Use the Lotus Eye Hospital stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Lotus Eye Hospital Market Cap
₹226.78 Cr.
LOTUSEYE P/E Ratio (TTM)
345.32
Lotus Eye Hospital P/B Ratio
3.67
EPS (TTM)
₹0.36
Dividend Yield
-
Debt to Equity
0.04
LOTUSEYE 52 Week High
₹141.38
Lotus Eye Hospital 52 Week Low
₹70.02
Operating Margin
5.00%
Profit Margin
1.89%
LOTUSEYE Revenue (TTM)
₹53.00
EBITDA
₹4.00
Net Income
₹1.00
Total Assets
₹70.00
Total Equity
₹60.00
Lotus Eye Hospital Share Price Chart
Screen Lotus Eye Hospital share price with an interactive chart. Analyse LOTUSEYE price trends and volatility across different timeframes.
Lotus Eye Hospital Company Profile - Fundamental Screener
Screen Lotus Eye Hospital company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for LOTUSEYE shares.
Sector
Healthcare Services
Industry
Hospitals
Sub-Sector
Hospitals
Segment
E
ISIN
INE947I01017
Lotus Eye Hospital Balance Sheet Screener
Screen LOTUSEYE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 70 | 67 | 63 | 62 | 59 | 58 | 57 | 58 | 55 | 55 |
| Current Assets | 12 | 14 | 15 | 13 | 14 | 11 | 7 | 8 | 7 | 6 |
| Fixed Assets | 54 | 49 | 44 | 44 | 41 | 43 | 44 | 43 | 41 | 44 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 2 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 60 | 59 | 58 | 55 | 53 | 51 | 50 | 51 | 50 | 50 |
| Share Capital | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 |
| Reserves & Surplus | 39 | 39 | 37 | 34 | 32 | 31 | 29 | 30 | 29 | 29 |
Lotus Eye Hospital Income Statement Screener - Profit & Revenue Analysis
Screen Lotus Eye Hospital income statement and profit fundamentals.
Analyze LOTUSEYE quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Lotus Eye Hospital share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 53 | 51 | 50 | 48 | 40 | 33 | 42 | 39 | 39 | 35 | 32 | 30 |
| Expenses | 49 | 46 | 42 | 40 | 33 | 29 | 37 | 35 | 34 | 31 | 27 | 28 |
| EBITDA | 4 | 5 | 8 | 9 | 7 | 4 | 5 | 4 | 5 | 4 | 5 | 3 |
| Operating Profit % | 5.00% | 7.00% | 14.00% | 16.00% | 15.00% | 11.00% | 9.00% | 8.00% | 11.00% | 10.00% | 13.00% | 7.00% |
| Depreciation | 2 | 3 | 4 | 3 | 3 | 2 | 3 | 3 | 3 | 3 | 4 | 5 |
| Interest | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 1 | 4 | 6 | 4 | 2 | 2 | 1 | 2 | 0 | 0 | -2 |
| Tax | 0 | 1 | 1 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 1 | 1 | 3 | 4 | 3 | 2 | 1 | 1 | 2 | 0 | 0 | -2 |
| EPS | 0.30 | 0.36 | 1.40 | 1.96 | 1.44 | 0.75 | 0.51 | 0.34 | 0.84 | 0.21 | 0.05 | -0.95 |
Lotus Eye Hospital Cash Flow Screener - Liquidity Fundamentals
Screen LOTUSEYE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 3 | 6 | 4 | 4 | 3 | 5 | 4 | 6 | 3 | 3 |
| Investing Activities | -6 | -5 | -2 | -4 | 1 | -1 | -4 | -4 | -1 | -1 |
| Financing Activities | -2 | -3 | -2 | -2 | 0 | 0 | -1 | -2 | 0 | -1 |
| Net Cash Flow | -5 | -2 | 1 | -1 | 3 | 4 | -1 | 0 | 2 | 2 |
Lotus Eye Hospital Shareholding Pattern Screener
See Lotus Eye Hospital shareholding pattern with promoter, FII, and DII holdings.
Check Lotus Eye Hospital promoter holding and ownership changes for LOTUSEYE on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 40.14% | 40.22% | 40.39% | 40.64% | 40.67% | 41.40% | 40.24% | 40.03% |
| FII Holding | 0.00% | 0.00% | 0.01% | 0.00% | 0.01% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.02% | 0.04% | 0.02% | 0.02% | 0.02% | 0.00% | 0.01% | 0.03% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 36.73% | 40.95% | 39.03% | 38.70% | 38.12% | 42.47% | 43.82% | 42.84% |
| Other Holding | 23.11% | 18.79% | 20.55% | 20.64% | 21.18% | 16.13% | 15.93% | 17.10% |
| Shareholder Count | 9,939 | 11,508 | 11,121 | 10,777 | 10,240 | 12,502 | 11,759 | 12,514 |
Lotus Eye Hospital Share Dividend Screener - Share Yield Analysis
Check Lotus Eye Hospital dividend history with payout and yield data.
View Lotus Eye Hospital dividend details including ex-dates and amounts for LOTUSEYE stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.50 | 0.87% |
| 2021-March | ₹0.50 | 0.94% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.50 | 2.27% |
| 2017-March | ₹0.50 | 1.81% |
Lotus Eye Hospital Stock Index Membership
See which indices include Lotus Eye Hospital stock.
Check LOTUSEYE index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Lotus Eye Hospital Market Events Screener - Corporate Actions
Get Lotus Eye Hospital corporate actions including splits, bonuses, and buybacks.
Check Lotus Eye Hospital stock events that may affect LOTUSEYE share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 12.18% | ||
| Dividend | ₹ 0.50 /share | -10.42% | ||
| Dividend | ₹ 0.50 /share | 37.48% | ||
| Dividend | ₹ 0.50 /share | 11.71% | ||
| 2026-05-26 | 2026-05-26 | Quarterly Result Announcement | NA | -2.68% |
| 2026-02-11 | 2026-02-11 | Quarterly Result Announcement | NA | -14.00% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -2.78% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | 0.12% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | -1.55% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | 2.12% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | -8.46% |
| 2024-08-13 | 2024-08-13 | Annual General Meeting | NA | 5.50% |
| 2017-06-06 | 2017-06-06 | Change Of Name | NA | - |
Lotus Eye Hospital Competitors Screener - Peer Comparison
Screen LOTUSEYE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Apollo Hospitals | 120,837 | 60.02 | 25,229 | 14.70% | 2,032 | 73.21 |
| Max Healthcare Institute | 97,396 | 69.05 | 8,373 | 16.56% | 1,464 | 44.00 |
| Fortis Healthcare | 73,257 | 73.94 | 9,128 | 16.28% | 1,064 | 61.20 |
| Narayana Hrudayalaya | 39,646 | 48.63 | 7,896 | 41.63% | 788 | 62.30 |
| Aster DM Healthcare | 38,698 | 91.78 | 4,643 | 8.32% | 384 | 58.59 |
| Global Health | 33,580 | 60.09 | 4,410 | 16.94% | 584 | 67.84 |
| Krishna Institute of Medical Sciences | 30,283 | 126.29 | 3,905 | 27.31% | 198 | 59.04 |
| Dr. Agarwal's Health Care | 15,197 | 90.43 | 2,080 | 18.39% | 168 | 65.24 |
| Rainbow Childrens Medicare | 13,710 | 52.98 | 1,567 | 17.46% | 244 | 65.06 |
| Park Medi World | 12,055 | 40.99 | 1,679 | 17.77% | 272 | 75.36 |
Lotus Eye Hospital Company Announcements - News Screener
Screen LOTUSEYE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-05-25 | Board Meeting Intimation for Standalone Audited Financial Results For The Quarter And Year Ended March 31 2026 | - |
| 2026-05-08 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-04-18 | Non-Applicability Of SEBI Circular On Large Corporates | - |
| 2026-04-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-26 | Closure of Trading Window | - |
| 2026-03-17 | Board Meeting Outcome for Outcome Of The Board Meeting | - |
| 2026-03-12 | Board Meeting Intimation for To Consider The Proposal For Voluntary Delisting Of The Companys Equity Shares From NSE. | - |
| 2026-03-04 | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | - |
| 2026-03-02 | Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011 | - |
| 2026-02-12 | Board Comments On Imposition Of Fine Under Regulation 17(1A) Of SEBI (LODR) 2015 | - |
| 2026-02-12 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-12 | Appointment of Company Secretary and Compliance Officer | - |
| 2026-02-11 | Outcome Of The Board Meeting | - |
| 2026-02-11 | Board Meeting Outcome for Outcome Of Board Meeting | - |
| 2026-02-09 | Announcement under Regulation 30 (LODR)-Cessation | - |
| 2026-02-06 | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 | - |
| 2026-01-30 | Board Meeting Intimation for The Quarter Ended 31St December 2025 | - |
| 2026-01-27 | Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011 | - |
| 2026-01-19 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-01-05 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |